The Vitamin D DANGER They Ignored (For Profit)
9 min
•Feb 20, 20263 months agoSummary
Dr. Berg argues that vitamin D has been unfairly demonized by mainstream medicine and pharmaceutical companies due to profit motives, not safety concerns. He explains two distinct vitamin D systems in the body—one for bone/calcium regulation and another (autocrine/paracrine) for immune function, brain health, and disease prevention—and contends that recommended doses are far too low to be therapeutically effective.
Insights
- Pharmaceutical industry has financial incentive to suppress vitamin D research since it could reduce demand for cancer drugs ($300B/year), autoimmune drugs ($10B+), and treatments for diabetes, hypertension, and depression
- Two separate vitamin D metabolic pathways exist with different requirements: bone regulation (600-800 IU/3 weeks) vs. immune/cellular function (8,000-10,000 IU daily), but medicine focuses only on the first
- Vitamin D toxicity is extremely rare and requires hundreds of thousands of IUs for months, whereas deficiency is common and linked to cancer risk, immune suppression, and metabolic dysfunction
- Medical establishment's fear-based messaging about sun exposure and vitamin D contradicts evolutionary biology and ignores that 20 minutes of summer sun provides 10,000 IUs naturally
- Magnesium and vitamin K2 are critical co-nutrients rarely studied alongside vitamin D, potentially explaining perceived toxicity risks that don't materialize in comprehensive protocols
Trends
Growing skepticism of pharmaceutical industry's influence on medical guidelines and research publication standardsShift toward understanding hormonal vs. nutritional roles of micronutrients in disease preventionIncreased interest in seasonal/cyclical nutrient protocols aligned with evolutionary biology rather than static RDAsRising focus on multi-nutrient synergy (vitamin D + K2 + magnesium) rather than isolated supplementationChallenge to sun-avoidance paradigm with emerging data on outdoor workers and melanoma riskExpansion of high-dose vitamin D protocols in functional medicine (Coimbra protocol for MS with 90% success rates)Questioning of 'safe dose' frameworks that prioritize avoiding toxicity over achieving therapeutic efficacyIntegration of gene expression (1,000+ genes regulated by vitamin D) into nutritional medicine discussions
Topics
Vitamin D deficiency and toxicity thresholdsPharmaceutical industry influence on medical guidelinesAutocrine and paracrine vitamin D systemsHigh-dose vitamin D protocols for autoimmune diseaseVitamin D and cancer risk reductionMagnesium and vitamin K2 co-supplementationSun exposure and melanoma riskSeasonal vitamin D cycling and metabolismGene expression regulation by vitamin DCoimbra protocol for multiple sclerosisMedical school curriculum gaps in biochemistryJournal publication bias against vitamin D researchSunscreen and vitamin D synthesis blockingIndoor lifestyle and vitamin D deficiencyEvolutionary biology and nutrient requirements
Companies
Harvard University
Conducted randomized clinical trial of 26,000 people showing vitamin D reduced autoimmune diseases by 22%
People
Dr. Coimbra
Brazilian doctor who developed Coimbra protocol for MS using high-dose vitamin D with reported 90% success rate
Quotes
"What happens to big pharma if vitamin D actually works? Cancer drugs right now make revenues like $300 billion a year."
Dr. Berg
"Vitamin D is not really a vitamin. A vitamin is typically something you get from food. Vitamin D is actually made by your own skin with the help of the raw material, cholesterol."
Dr. Berg
"20 minutes of summer sun will give you 10,000 IUs of vitamin D3. Is that toxic?"
Dr. Berg
"Vitamin D toxicity is extremely rare. You'd have to take hundreds of thousands of international units of vitamin D3 for months, many months, before you start developing one problem."
Dr. Berg
"Is it safe to take high doses of vitamin D3? But we never ask this question right here. Is it safe to be deficient in vitamin D?"
Dr. Berg
Full Transcript